Jul 26, 2019 / 01:00AM GMT
Presentation
Jul 26, 2019 / 01:00AM GMT
=====================
Corporate Participants
=====================
* Osamu Okuda
Chugai Pharmaceutical Co., Ltd. - Executive VP and Co-Head of Project, Lifecycle Management Unit & Foundation Medicine
* Tatsuro Kosaka
Chugai Pharmaceutical Co., Ltd. - President, CEO & Representative Director
* Toshiaki Itagaki
Chugai Pharmaceutical Co., Ltd. - EVP, CFO and GM of Finance Supervisory Division, Finance & Accounting Dept.
* Yasushi Ito
Chugai Pharmaceutical Co., Ltd. - Executive VP and Co-Head of Project & Lifecycle Management Unit
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc, Research Division - MD and Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Research Division -
Chugai Pharmaceutical Co Ltd
(OTCPK:CHGCF)
$
43.78
-3.2505 (-6.91%)
Market Cap: 73.00 Bil
Enterprise Value: 73.11 Bil
PE Ratio: 27.66
PB Ratio: 6.65
GF Score: 81/100 Q2 2019 Chugai Pharmaceutical Co Ltd Earnings Presentation Transcript
Jul 26, 2019 / 01:00AM GMT
Release Date Price:
$21.35
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot